News

News 17.05.2022 ZURICH-SCHLIEREN, Switzerland, May 16, 2022 – DiNAQOR announced today the launch of DiNAQOR DiNAMIQS, a biomanufacturing subsidiary, that will accelerate development timelines and reduce costs and risk for genetic medicine companies bringing new treatments to market. DiNAQOR DiNAMIQS is based in the company’s state-of-the-art, 1,200-square-meter (13,000 square feet) manufacturing facility in...

News 13.05.2022 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 12, 2022 (GLOBE NEWSWIRE) --  Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced its interim management statement for the quarter ending...

News 11.05.2022 Zurich-Schlieren, Switzerland and Avellino, Italy, May 11, 2022 – Diagnostica Medica of Mercogliano (Avellino), Italy, and Proteomedix, the Swiss cancer diagnostics company, announced today that Proclarix®, a new blood test for the management of prostate cancer patients, has been introduced in the routine of the laboratory that is part of...

News 03.05.2022 BASEL, Switzerland and ZURICH-SCHLIEREN, Switzerland, May 03, 2022 (GLOBE NEWSWIRE) -- The Swiss Biotech Association and Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that Molecular Partners’ Chief Executive Officer Patrick Amstutz, Ph.D.,...

News 28.04.2022 Schlieren (Zurich), Switzerland, April 27, 2022 – Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies, today provided a first-quarter business update, showing a significant acceleration in product sales of its Medical devices segment. Medical devices sales increased 102% in Q1 2022 compared to Q1 2021. The U.S....